Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 06 2020
Historique:
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 2 1 2021
Statut: ppublish

Résumé

Synucleinopathies such as multiple system atrophy (MSA) and Parkinson's disease are associated with a variety of visual symptoms. Functional and morphological retinal aberrations are therefore supposed to be valuable biomarkers for these neurodegenerative diseases. This study examined the retinal morphology and functionality resulting from human α-synuclein (α-Syn) overexpression in the transgenic Plp-α-Syn mouse model. Immunohistochemistry on retinal sections and whole-mounts was performed on 8- to 11-week-old and 12-month-old Plp-α-Syn mice and C57BL/6N controls. Quantitative RT-PCR experiments were performed to study the expression of endogenous and human α-Syn and tyrosine hydroxylase (TH). We confirmed the presence of human α-Syn in the retina in western blot analyses. Multi-electrode array (MEA) analyses from light-stimulated whole-mounted retinas were used to investigate their functionality. Biochemical and immunohistochemical analyses showed human α-Syn in the retina of Plp-α-Syn mice. We found distinct staining in different retinal cell layers, most abundantly in rod bipolar cells of the peripheral retina. In the periphery, we also observed a trend toward a decline in the number of retinal ganglion cells. The number of TH+ neurons was unaffected in this human α-Syn overexpression model. MEA recordings showed that Plp-α-Syn retinas were functional but exhibited mild alterations in dim light conditions. Together, these findings implicate an impairment of retinal neurons in the Plp-α-Syn mouse. The phenotype partly relates to retinal deficits reported in MSA patients. We further propose the suitability of the Plp-α-Syn retina as a biological model to study synuclein-mediated mechanisms.

Identifiants

pubmed: 32503050
pii: 2766307
doi: 10.1167/iovs.61.6.12
pmc: PMC7415298
doi:

Substances chimiques

Glial Fibrillary Acidic Protein 0
Myelin Proteolipid Protein 0
alpha-Synuclein 0
glial fibrillary astrocytic protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Références

EMBO Rep. 2002 Jun;3(6):583-8
pubmed: 12034752
Brain Pathol. 2016 May;26(3):404-9
pubmed: 26940152
Mov Disord. 2013 Mar;28(3):347-55
pubmed: 23426727
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S62-7
pubmed: 24262191
Neuron. 2016 May 18;90(4):675-91
pubmed: 27196972
Science. 2004 Aug 27;305(5688):1292-5
pubmed: 15333840
Exp Eye Res. 2010 Aug;91(2):286-92
pubmed: 20621651
Mov Disord. 2007 Nov 15;22(15):2196-203
pubmed: 17853477
Neuroreport. 2012 Mar 7;23(4):259-64
pubmed: 22314685
Neurology. 2017 Jun 6;88(23):2233-2235
pubmed: 28490649
J Neurol Sci. 1989 Dec;94(1-3):79-100
pubmed: 2559165
Mov Disord. 2014 Jan;29(1):15-22
pubmed: 24339212
Parkinsons Dis. 2011;2011:908306
pubmed: 21687773
J Clin Neurophysiol. 2006 Oct;23(5):431-5
pubmed: 17016154
PLoS One. 2014 Feb 25;9(2):e89327
pubmed: 24586691
Neuropathol Appl Neurobiol. 2016 Feb;42(1):20-32
pubmed: 26785838
Front Aging Neurosci. 2017 Jul 06;9:214
pubmed: 28729832
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28108534
Brain. 1997 Dec;120 ( Pt 12):2219-28
pubmed: 9448577
Eye (Lond). 2017 Feb;31(2):209-217
pubmed: 28085141
Neurotherapeutics. 2016 Oct;13(4):871-879
pubmed: 27259295
J Parkinsons Dis. 2016;6(1):39-51
pubmed: 27003784
Neuroscience. 2010 May 19;167(3):786-98
pubmed: 20188150
Nat Rev Neurol. 2013 Jan;9(1):44-53
pubmed: 23165340
J Neurophysiol. 2011 Apr;105(4):1516-30
pubmed: 21273316
Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98
pubmed: 25428349
Front Mol Neurosci. 2018 Aug 24;11:293
pubmed: 30197586
Neuropathology. 2006 Aug;26(4):338-45
pubmed: 16961071
Commun Integr Biol. 2010 Mar;3(2):106-9
pubmed: 20585500
Neurology. 2003 Sep 9;61(5):686-9
pubmed: 12963764
Neurobiol Dis. 2019 Jan;121:1-16
pubmed: 30218757
Channels (Austin). 2013 Nov-Dec;7(6):503-13
pubmed: 24051672
Invest Ophthalmol Vis Sci. 2012 May 04;53(5):2476-81
pubmed: 22562845
Nat Methods. 2019 Dec;16(12):1226-1232
pubmed: 31570887
Trends Biochem Sci. 1990 Aug;15(8):305-9
pubmed: 2204156
Neurosci Lett. 1998 Jun 19;249(2-3):180-2
pubmed: 9682846
Lancet Neurol. 2009 Dec;8(12):1172-8
pubmed: 19909915
Ann Neurol. 2014 Jun;75(6):964-6
pubmed: 24816946
Dev Biol. 2006 Feb 15;290(2):277-86
pubmed: 16388796
J Neuropathol Exp Neurol. 2011 Jan;70(1):63-8
pubmed: 21157377
N Engl J Med. 2015 Apr 2;372(14):1375-6
pubmed: 25830435
J Parkinsons Dis. 2017;7(s1):S51-S69
pubmed: 28282814
Ann Neurol. 1998 Sep;44(3):415-22
pubmed: 9749615
J Neurol. 2016 Oct;263(10):2039-47
pubmed: 27416856
J Neurosci. 2005 Nov 16;25(46):10689-99
pubmed: 16291942
Brain. 2013 Jul;136(Pt 7):2130-46
pubmed: 23757764
Clin Neurophysiol. 2000 Jan;111(1):66-74
pubmed: 10656512
Brain. 1987 Apr;110 ( Pt 2):415-32
pubmed: 3567530
J Neurosci. 2016 Mar 2;36(9):2827-42
pubmed: 26937019
J Comp Neurol. 2015 Dec 15;523(18):2788-806
pubmed: 26011242
Exp Neurol. 2010 Aug;224(2):459-64
pubmed: 20493840
Exp Neurol. 2013 Sep;247:531-6
pubmed: 23399889
Acta Neuropathol. 2010 Jun;119(6):657-67
pubmed: 20309568
Clin Exp Optom. 2014 Nov;97(6):483-91
pubmed: 25256122
Nat Neurosci. 2017 Oct 26;20(11):1514-1515
pubmed: 29073642
Mov Disord. 1998 May;13(3):446-52
pubmed: 9613735
Brain. 1994 Aug;117 ( Pt 4):835-45
pubmed: 7922469
Invest Ophthalmol Vis Sci. 2012 Aug 17;53(9):5653-64
pubmed: 22743325
J Neurosci. 2004 Feb 25;24(8):1888-96
pubmed: 14985429
Brain. 2015 Aug;138(Pt 8):2293-309
pubmed: 25981961
Curr Top Behav Neurosci. 2015;22:369-93
pubmed: 24338664
J Neurol Sci. 2015 Aug 15;355(1-2):44-8
pubmed: 26071887
J Biol Chem. 1997 May 23;272(21):13877-82
pubmed: 9153247
Front Cell Neurosci. 2013 Jan 09;6:60
pubmed: 23316132
Doc Ophthalmol. 2004 Jan;108(1):17-40
pubmed: 15104164
PLoS One. 2013 May 17;8(5):e64625
pubmed: 23691255
Invest Ophthalmol Vis Sci. 1988 Sep;29(9):1363-71
pubmed: 3417421
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):235-41
pubmed: 22878471
Vision Res. 2014 Aug;101:108-17
pubmed: 24959652
BMJ Open. 2016 May 06;6(5):e009658
pubmed: 27154474
Parkinsonism Relat Disord. 1999 Dec;5(4):157-62
pubmed: 18591134
Nat Neurosci. 2015 Jan;18(1):66-74
pubmed: 25485757
Mov Disord. 2015 Dec;30(14):1944-53
pubmed: 26359930
Mov Disord. 2018 Aug;33(8):1315-1324
pubmed: 29737566
Acta Neuropathol Commun. 2018 Jan 3;6(1):2
pubmed: 29298733
J Neurol Sci. 1992 Feb;107(2):172-82
pubmed: 1314292
Front Neurol. 2017 May 24;8:206
pubmed: 28596752
Histochem Cell Biol. 2016 Feb;145(2):147-61
pubmed: 26563642
Brain. 1987 Dec;110 ( Pt 6):1675-98
pubmed: 3427405
Front Behav Neurosci. 2017 Jan 10;10:252
pubmed: 28119583
Biochim Biophys Acta. 2014 Aug;1838(8):2053-65
pubmed: 24796500
PLoS One. 2014 Aug 28;9(8):e106148
pubmed: 25165854
Neurosci Lett. 2014 Jun 13;571:34-8
pubmed: 24785101
Neurosci Lett. 1998 Jul 31;251(3):205-8
pubmed: 9726379
Biomolecules. 2015 Apr 14;5(2):435-71
pubmed: 25874605

Auteurs

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH